Comparative Efficacy of Treatments for Moderate-to-Severe Plaque Psoriasis: An Updated Network Meta-Analysis (NMA)
April W. Armstrong, MD, MPH, Ahmed M. Soliman, MS, PhD, Lluís Puig, MD, PhD, Keith A. Betts, PhD, Yan Wang, ScD, and Yawen Gao, MA
Demographic and Clinical Factors Associated with Patient-Reported Remission in Psoriasis
George Gondo, MA, Megan Mosca, Julie Hong, Emanual Maverakis, MD, April Armstrong, MD, MPH, Joseph F. Merola, MD, MSCE, Tina Bhutani, MD, Stacie J Bell, PhD, and Wilson Liao, MD
Efficacy and Safety of Deucravacitinib, an Oral, Selective TYK-2 Inhibitor Compared to Placebo and Apremilast in Moderate to Severe Plaque Psoriasis: Results from the POETYK PSO-1 and PSO-2 Studies
Melinda Gooderham, Richard Warren, Kim Papp, Bruce Stober, Diamant Thaci, April W. Armstrong, et al.
Faculty
|
April W. Armstrong, MD, MPH |
Professor of Dermatology Associate Dean for Clinical Research Director of Clinical Research Support, Southern California Clinical and Translational Science Institute (SC CTSI) Vice Chair, Director of Clinical Trials and Outcomes Research Director, Psoriasis Program Department of Dermatology Keck School of Medicine University of Southern California Los Angeles, CA |
